Human Health Effects:
Toxicity Summary:
IDENTIFICATION: Aluminum
is a silvery-white, ductile and malleable metal. It is released to the
environment both by natural processes and from anthropogenic sources. It is
highly concentrated in soil-derived dusts from such activities as mining and
agriculture, and in particulate matter from coal combustion. Aluminum
occurs ubiquitously in the environment in the form of silicates, oxides and
hydroxides, combined with other elements such as sodium and fluorine and as
complexes with organic matter. It is not found as a free metal because of its
reactivity. Aluminum metal has a wide
variety of uses, including structural materials in construction, automobiles and
aircraft, and the production of metal alloys. Aluminum
compounds and materials also have a wide variety of uses, including production
of glass, ceramics, rubber, wood preservatives, pharmaceuticals and
waterproofing textiles. Natural aluminum
minerals, especially bentonite and zeolite, are used in water purification,
sugar refining, brewing and paper industries. HUMAN EXPOSURE: Non-occupational
human exposure to aluminum in the
environment is primarily through ingestion of food and water. No acute
pathogenic effects in the general population have been described after exposure
to aluminum. Although it has been
hypothesized that aluminum is a risk
factor for Alzheimer's disease, present epidemiological evidence does not
support a causal association between Alzheimer's disease and aluminum
in drinking-water. Neurological syndromes including impairment of cognitive
function, motor dysfunction and peripheral neuropathy have been reported in
limited studies of workers exposed to aluminum
fume. Iatrogenic exposure in patients with chronic renal failure, exposed to aluminum-containing
dialysis fluids and pharmaceutical products, may cause encephalopathy,
vitamin-D-resistant osteomalacia and microcytic anemia. Premature infants may
develop increased tissue loading of aluminum,
particularly in bone, when exposed to iatrogenic sources of aluminum.
Although human exposure to aluminum is
widespread, in only a few cases has hypersensitivity been reported following
exposure to some aluminum compounds
after dermal application or parenteral administration. There is insufficient
information to allow for classification of the cancer risk from human exposures
to aluminum and its compounds. Aluminum
and its compounds appear to be poorly absorbed in humans. The mechanism of
gastrointestinal absorption of aluminum
has not yet been fully elucidated. The highest levels of aluminum
may be found in the lungs, where it may be present as inhaled insoluble
particles. The urine is the most important route of aluminum
excretion. ANIMAL STUDIES: The acute toxicity of metallic aluminum
and aluminum compounds is low. In
short-term studies using rats, mice or dogs to various aluminum
compounds in the diet or drinking-water, only minimal effects were observed at
the highest administered doses. Adequate inhalation studies were not identified.
Following intratracheal administration of aluminum
oxide, particle-associated fibrosis was observed. No overt fetotoxicity was
noted, nore were general reproductive parameters noted after gavage treatment of
rats. There is no indication that aluminum
is carcinogenic. It can form complexes with DNA and cross-link chromosomal
proteins and DNA, but it has not been shown to be mutagenic in bacteria or
induce mutation or transformation in mammalian cells in vitro. Chromosomal
aberrations have been observed in bone marrow cells of exposed mice and rats.
There is considerable evidence that aluminum
is neurotoxic in experimental animals, although there is considerable variation
among species. In susceptible species, toxicity following parenteral
administration is characterized by progressive neurological impairment,
resulting in death with status epilepticus. Osteomalacia, as it presents in man,
is observed consistently in larger species (e.g. dogs and pigs) exposed to aluminum;
a similar condition is observed in rodents. Absorption via the gastrointestinal
tract is usually less than one percent. Aluminum
is distributed in most organs within the body with accumulation occurring mainly
in bone at high dose levels. To a limited extent, aluminum
passes the blood-brain barrier and is also distributed to the fetus. Aluminum
is eliminated effectively by urine.
Human Toxicity Excerpts:
ACROANESTHESIA ... NUMBNESS OF FINGERS, IS
REPORTED FROM COTTON MILLS IN OPERATIONS WHERE THERE IS LONG CONTACT WITH ALUMINUM
IN WET BOBBIN WINDING.
FOUND PNEUMOTHORAX AT NECROPSY ON A MAN WHO
HAD BEEN EXPOSED TO PURE ALUMINUM DUST
... LUNG SHOWED INDURATION AND DESTRUCTION OF PARENCHYMA ... COLLAGEN DEPOSITION
AND HYALINE CHANGE WERE FOUND IN LUNGS OF 5 CO-WORKERS ... /ALUMINUM
DUST/
CHRONIC LUNG DISEASE IN JAPAN ... MAN 32 WHO
DIED AFTER HAVING BEEN EXPOSED FOR 3.5 YR TO METALLIC ALUMINUM
DUST. MAIN NECROPSY FINDINGS WERE CHRONIC INTERSTITIAL PNEUMONIA WITH SEVERE
CAVITATION IN RIGHT UPPER LOBE & NUMEROUS SMALL CAVITIES IN REST OF BOTH
LUNGS. /METALLIC ALUMINUM DUST/
CLINICAL PICTURE /FROM INHALATION OF ALUMINUM
DUST/ CONSISTS OF DYSPNEA, COUGH, PNEUMOTHORAX, & VARIABLE SPUTUM
PRODUCTION, WITH FATAL OUTCOME NOT UNCOMMON. CHEST FILM & HISTOPATHOLOGY ARE
... NODULAR INTERSTITIAL FIBROSIS. /ALUMINUM
DUST/
ALUMINUM
FIBROSIS OF LUNG WITH ENCEPHALOPATHY WAS REPORTED. ... PRESENTING SYMPTOMS WERE
REFERABLE TO CNS, & DEATH RESULTED FROM BRONCHOPNEUMONIA FOLLOWING
PROGRESSIVE ENCEPHALOPATHY ASSOC WITH EPILEPTIFORM SEIZURES, ALTHOUGH
RADIOGRAPHIC EXAM OF CHEST OF 53 OTHER FACTORY WORKERS & CLINICAL EXAM OF 23
OF THEM REVEALED NO DEFINITE CASES OF ALUMINUM
FIBROSIS. ALUMINUM CONTENT OF BRAIN
AND LUNG WAS ABOUT 20 TIMES NORMAL ... .
INHALATION OF FINE PARTICLES OF ALUMINUM
METAL DUST IN FACTORIES CAUSED ... PROGRESSIVE ENCEPHALOPATHY ... FOLLOWED BY
DEMENTIA & CONVULSIONS; THE BRAIN SHOWED A UNIQUE CELLULAR CHANGE,
NEUROFIBRILLARY DEGENERATION. /METALLIC ALUMINUM
DUST/
A cross-sectional study was performed to
clarify a possible role of atopy in the occurrence of acute bronchoconstrictive
impairment observed in workers in a plant for the electrolytic extraction of aluminum.
At the time of examination, mean hydrogen fluoride exposure was 0.56 mg/cu m,
mean particulate fluoride exposure was 0.15 mg/cu m, and mean sulfur dioxide
concentration was 3.38 mg/cu m. No information on duration of exposure or
employment is provided. Of 227 workers examined (mean age 37, 43% current
smokers) the percentage of those with a history of atopy and positive skin tests
for common allergens was within the expected range. Six had a positive patch
test with 2% sodium fluoride among 7 workers with paroxysmal wheezing and
dyspnea, of whom 3 were light smokers, 3 had positive skin tests with common
allergens but only 1 had an increased IgE value. The same worker also had a
positive patch test with 2% sodium fluoride. Two had symptoms defined as chronic
bronchitis. FEV's, with 2 exceptions, measured at the beginning of the workshift
were within normal limits. In 5 of the 7 workers, nonspecific bronchoprovocative
tests with histamine or metacholine indicated objectively the presence of
bronchial hyperreactivity.
Aluminum
is not generally regarded as an industrial poison. Inhalation of finely divided aluminum
powder has been reported as a cause of pulmonary fibrosis. May be implicated in
Alzheimers disease.
MAJOR HEALTH PROBLEM IN ALUMINUM
REDUCTION PLANTS IS NO LONGER FLUOROSIS, BUT POSSIBLE EFFECTS TO COAL TAR PITCH
VOLATILES & THEIR ASSOC POLYCYCLIC AROMATIC HYDROCARBONS ... .
THE MAIN HEALTH HAZARD IN PRIMARY ALUMINUM
PRODUCTION IS FLUORIDE EXPOSURE, NOT EXPOSURE TO ALUMINUM
OR ALUMINUM OXIDE. BOTH GASEOUS &
PARTICULATE FLUORIDES ARE FOUND IN THE WORKING ATMOSPHERE AS WELL AS IN THE
EMISSIONS.
Pulmonary aluminosis is a disease first seen
in Germany between 1938 and 1945 which then reappeared in the United Kingdom
between 1952 and 1959. All cases were associated with exposure to a submicron-sized
aluminum pyrotechnic flake which was
lubricated with a non-polar aliphatic oil. Ordinarily, stearic acid, which
chemically combines with aluminum to
form aluminum stearate, was used as a
lubricant to retard surface oxidation during milling of such flake. This new
aliphatic lubricant, which simply physically coated the flakes to prevent
elemental aluminum oxidation, could be
easily washed off of such flakes. In the intracellular milieu, removal of such
surface oil permits exposure of oxygen to elemental aluminum;
this results in a vigorous exothermic reaction and the potential for tissue
damage. It appears that cases occurred only where this oily lubricant was used
to manufacture near submicron-sized pyrotechnic flake (ie, United Kingdom,
Germany, Sweden), but never where similar flakes have been manufactured for
almost a century using polar lubricants.
THERE IS SOME EVIDENCE THAT @ INTAKE LEVELS
CONSIDERABLY HIGHER THAN NORMAL THERE IS TENDENCY FOR BODY TO BECOME DEPLETED OF
/PHOSPHORUS/, OWING TO BINDING OF DIETARY PHOSPHATE BY ALUMINUM
IN DIGESTIVE TRACT.
LOCALLY IN SOLN ... /ALUM IS/ RARELY
IRRITATING BUT THE DRY POWDER MAY CAUSE MARKED INFLAMMATION OR CORROSION OF THE
SKIN & MUCOUS MEMBRANES. WHEN INGESTED AS CONCN SOLN OR AS SOLID ... THERE
IS GI IRRITATION OR CORROSION, WITH NAUSEA, VOMITING, ABDOMINAL PAIN &
DIARRHEA.
Nineteen young male workers exposed
occupationally from 1975-1977 to inhaled particles of aluminum
fluoride or sulfate at two plants, developed nocturnal wheezing and
breathlessness with reversible airways obstruction after an average of 4 mo
employment. At standardized methacholine provocation tests, 17 of 19 workers
with normal spirometry showed airway hyperreactivity with a fall of FEV1 forced
expiratory volume in 1 sec of greater than or equal to 15% after 0.1%
methacholine. Fifteen initially asthmatic workers were followed for 2-5 yr with
methacholine provocation tests. Mean TD (threshold dose) 15% FEV1 in 11 workers
did not change significantly after an average of 41 mo of nonexposure. Six
workers continuously exposed for 48 mo also failed to change normal airway
reactivity. /Aluminum salts/
Nuclear and chromatin fractions were prepared
from the cerebral cortex of 34 human and 37 animal brains. Chromatin was
separated into a heavy heterochromatin fraction and two euchromatin fractions:
intermediate euchromatin and light euchromatin. Compared to age-matched
controls, aluminum content expressed
per gram of DNA was significantly increased in nuclear and heterochromatin
fractions in pre-senile Alzheimer's disease. In contrast, nuclear preparations
from brains of patients who had died with dialysis encephalopathy contained less
aluminum than controls, although whole
tissue concn were elevated ten to fifteen times above the control concn. Direct
injection of aluminum into the
cerebrospinal fluid of cats resulted in a progressive encephalopathy with
neurofibrillary degeneration and increased intranuclear aluminum
content. It is speculated that in Alzheimer's disease, the normal blood-brain
and cytoplasmic barriers for this neurotoxic metal are defective, permitting aluminum
to gain access to DNA-containing constituents of the nuclei.
Though the etiology of the dialysis dementia
has not been conclusively established, there is ample evidence to implicate aluminum
as the causative agent for this fatal syndrome. ... Dialysis dementia is a
severe syndrome characterized by progressive neurological impairment, speech
disorders, dysarthria, dyspraxia, dysphasia, aphemia, amnesia, mutism, facial
grimacing and myoclonus. Of sixty dialysis dementia cases recently reviewed, 87%
exhibited disturbances in communication, 66% in cognition and 93% in movement.
The onset is usually insidious, with the first symptoms occurring after a mean
of 37 mo from the beginning of the dialysis treatment. Hesitant, stuttering,
misarticulated and non-fluent speech, difficulty in concentration, diurnal
drowsiness, reduction of attention span, poor memory, dysgraphia and twitching
of limbs are usually the earliest signs. Patients exhibit a very characteristic
electroencephalogram demonstrating paroxysmal slowing, diffuse rhythmical
bursts, with diphasic or triphasic spiked waves in the high-voltage delta
frequency range in the initial early stages and only pronounced generalized
delta and theta activity late in the course of the dialysis dementia. Reports
exist on possible epileptogenic activity arising in the middle diencephalon and
a few indicate localized cortical atrophy. Low protein content in the frontal
grey matter may indicate that dialysis encephalopathy is accompanied by defects
in the blood-brain barrier. Episodic apnea was also related to the EEG
abnormality with intermittent respiratory arrest occurring simultaneously with
paroxysmal slowing. ... The actual pathogenesis is complicated, since the
symptoms are developed in some patients and not in other equally exposed
patients. This can be attributed to the rate of exposure or peak free aluminum
concn as well as other factors, such as parathyroid hormone, that affects aluminum
absorption and/or distribution, and the impairment of some functions of the
central nervous system.
On occasion workers chronically exposed to aluminum-containing
dusts or fumes have developed severe pulmonary reactions including fibrosis,
emphysema and pneumothorax. A much rarer encephalopathy has also been described.
The factors which predispose to lung damage are not well characterized. ... /Aluminum
(dust or fumes)/
Fluorosis. Inhalation of fluoride poses a
potential hazard in workers in primary aluminium
production, but the majority of workers are clinically unaffected. Clinical
fluorosis, which is rare, commences with stiffness in the lower back followed by
pain and then limitation of rotation of the trunk. Later, the spine becomes
rigid and stiff, with restriction of chest movement and of the large joints,
particularly the hip, that is accompanied by osteosclerosis. /Aluminum
fluorides/
May cause minor irritation to lungs &
eyes.
The high levels of aluminum
found in the brain tissue of uremic patients who died are thought to be the
cause of dialysis encephalopathy. Aluminum
in the water supply and in phosphate binding gels is the likely source. Aluminum
toxicity also is manifested by abnormal accumulation in bone. Osteomalacia is
rare when aluminum-free dialysate is
used and oral aluminum ingestion is
minimized.
Certain dusts produce primarily interstitial
fibrotic disease (eg, acute berylliosis, aluminosis, asbestosis) rather than the
focal nodular lesions seen in simple pneumoconiosis. Fibrotic lesions appear out
of proportion to the presence of dust-laden macrophages. /Aluminum
dust/
The metal itself is a health risk when it
occurs as a fine powder, usually called stamped aluminum
powder. Exposure to such aluminum
powder at high concentrations may give rise to fibrosis of the lung, that is,
aluminosis.
Use of aluminum
saucepans, aluminum-lined cooking
utensils and containers may increase the content of aluminum
in food. This is particularly true when acidic foodstuffs are stored in aluminum
utensils. Rhubarb cooked in an aluminum
saucepan contained 25 mg per normal portion compared to 0.1 mg aluminum
per portion in rhubarb cooked in a stainless steel saucepan. Normally, the
addition of aluminum to the diet from
cooking utensils is minimal and has been assumed to have no toxicological
significance. Taking antacids which contain aluminum
increases daily intake by 0.2-3 g, ie, approximately 100 times the normal intake
from food-stuffs. Daily doses of several grams of aluminum
are not unusual in individuals using antacids.
Hazardous exposures are confined to the
production of aluminum and the making
of aluminum abrasives; dusts and fumes
in the reduction plants consist of alumina dust and fume, cryolite, ... the
fluorides of aluminum, coal tar pitch
volatiles consisting of 14 identified polycyclic aromatic hydrocarbons, carbon
monoxide, and sulfur dioxide. ... The production of aluminum
abrasives, however, in which bauxite, iron, coke, and silica are fused at 2000
deg C, poses the threat of Shaver's disease, an often fatal and rapidly
progressive interstitial fibrosis of the lung, unless exposures are properly
controlled. Present-day control measures have almost removed the threat. /Aluminum
fluorides/
Fumes from an aluminum
soldering flux have been reported to result in a delayed type of asthma
resembling pollen-sensitivity asthma, rather than the infiltrative type seen in
farmer's lung. Delayed and prolonged bronchoconstriction was investigated by
serial spirometry, peak flow rates, and body plethysmography after the
inhalation of small amounts of flux fumes. Because similar responses were
obtained after inhalation of (aminoethyl) ethanolamine, one of the major flux
constituents, it was presumed to be the active allergic agent. If the inert-gas,
tungsten-ore process is used in aluminum
welding the asthma problem is eliminated, but this process can lead to upper
respiratory symptoms (chest tightness and wheezing from edema) unless ozone
exposures are kept below 0.2 ppm.
Recently reported adverse effects of aluminum
in humans have resulted from inhalation or ingestion of aluminum
in concentrations many times greater than the amounts present in normal
circumstances. Following large oral doses of aluminum,
toxic syndromes involve gastrointestinal tract irritation and eventually,
interference with phosphate absorption, which results in rickets. Industrial
exposure to high concentrations of aluminum-containing
airborne dusts has resulted in a number of cases of occupational pneumoconiosis.
Most of these exposures were chronic, and other substances were involved in
nearly all instances. For example, an asthma-like disease has been reported in
workers engaged in the production of aluminum
from its oxide. This condition may result from the hydrogen fluoride that
evolves from the use of fluorine-bearing materials in the production of metallic
aluminum. Silicosis, aluminosis, aluminum
lung, and bauxite pneumoconiosis are the result of pulmonary fibrotic reactions
to silical and aluminum-containing
compounds, which have been observed in the lung tissue in humans. Pardoxically, aluminum
powder has been used in the prevention and therapy of silicosis. The rationale
is that small amounts of metallic aluminum
inhibit the solubility of siliceous materials in the lungs or diminish their
fibrogenic properties. There is no unequivocable evidence that the procedure is
clinically effective.
Variable degrees of bony fluorosis have been
seen. The first stage of this condition consists simply of an increase in bone
density, particularly marked in the vertebral bodies and pelvis.
A report from Italy indicated that aluminum
production workers may also suffer from pneumoconiosis. Chest X-ray examination
of 119 potroom workers and a similarly sized control group revealed tht the
exposed group included significantly more cases of suspected and definite
pneumoconiosis (30%) than the control group (15%). Small inorganic fibrous
particles have been discovered in the potrooms of the Norwegian aluminum
industry. The health significance of this finding is as yet unknown.
Asthma, chronic pulmonary disease and skin
lesions occur in potroom workers. Fluorosis has occurred in workers in the aluminum
production industry.
The available epidemiological studies provide
limited evidence that ... exposures ... are carcinogenic to humans, giving rise
to cancer of the lung and bladder. A possible causative agent is pitch fume.
There is inadequate evidence that occupational exposures in the aluminum
production industry result in haematolymphopoietic and pancreatic cancer. There
is sufficient evidence that samples of particulate polynuclear organic matter
from one aluminum production plant
were carcinogenic to experimental animals. However, because of the incomplete
characterization of the samples tested, no evaluation of the carcinogenicity to
experimental animals of complex mixtures that occur in the aluminum
production industry could be made. A number of individual polynuclear aromatic
compounds for which there is sufficient evidence of carcinogenicity in
experimental animals have been measured at high levels in air samples taken from
certain areas in aluminium production
plants. Taken together, the available evidence indicates that certain exposures
in the aluminum production industry
are probably carcinogenic to humans.
In chronic renal failure, aluminum
overload may influence parathyroid function. In a study of possible aluminum-induced
parathyroid abnormalities, parathyroid glands from nine parathyroidectomized
patients on hemodialysis were examined by light and electron microscopy and by
X-ray microanalysis. Aluminum overload
was assessed by the presence of stainable aluminum
(aluminum surface, 233% + or - 11% of
total surface) in bone biopsy specimens. The mean plasma aluminum
concentration was 7.7 + or - 1.9 umol/l. All patients but one had elevated
plasma concentrations of immunoreactive parathyroid hormone as well as osteitis
fibrosa. The aluminum concentrations
in bone and parathyroid gland from these patients were significantly higher than
those in tissue from patients on hemodialysis without stainable bone aluminum.
Abundant aluminum deposits were
present in parathyroid chief cell cytoplasm in lipoid bodies, lipofuscin
granules, and mitochondria. These cells exhibited features of active hormonal
synthesis and contained numerous secretory granules. The data show that in the
parathyroid glands of these aluminum-intoxicated
patients the presence of aluminum
deposits neither induced cellular damage or cheif cell necrosis nor interfered
with the production of parathyroid hormone.
... Serum aluminum
concentrations /were measured/ in 104 hemodialysis patients from 3 centers in
Hong Kong. It was found that the 52 patients dialyzed in unit A had much higher
mean aluminum levels (100 ug/l) than
those from the other two units (61 and 39 ug/l respectively). In unit A, where
water treatment by reverse osmosis had been introduced only recently, 30.8% of
patients had fractures/Looser zones, 46.2% had rugger-jersey spine and 28.8% had
skeletal erosions. When these patients were divided into two groups according to
whether their serum aluminum
concentration was below or above 100 ug/l, the latter patients had significantly
lower alkaline phosphatase, serum phosphate, and higher total prescribed dose of
aluminum hydroxide. It was concluded
that both dialysate aluminum and oral aluminum
intake seemed to have contributed to the high incidence of osteomalacic
fractures among Unit A patients. In eight of these patients serum aluminum
increased by more than 150 ug/l after four weeks of receiving 1.5 g
desferrioxamine twice weekly. Serial X-rays showed that the mean time after
dialysis for the appearance of fractures/Looser zones was 72 months. Three
patients developed fractures/Looser zones after successful renal
transplantation; and it was postulated that the prompt excretion of aluminum
permitted increased osteoclastic activity, resulting in fractures in these
patients.
Application ofmolecular biological techniques
and sensitive elemental analysis have produced new evidence implicating aluminum
as an important factor in down regulation of neuronal protein metabolism. Aluminum
in Alzheimer's disease may act by electrostatically crosslinking proteins,
particularly the methionine containing histone H1 degree, and DNA. The
consequence of such crosslinking is reduced transcription of at least one neuron
specific gene, the low molecular weight component of neurofilaments. In the
superior temporal gyrus in Alzheimer's disease down regulation of this gene
occurs in approximately 86% of surviving neurons and, therefore, aluminum
must be considered as having active role in the pathogenesis. Epidemiological
studies are reviewed that independently support the hypothesis that
environmental aluminum is a
significant risk factor. Preliminary evidence also suggests that a disorder in
phosphorylation may be an important initiating factor. /Aluminum/
Bone abnormalities may complicate parenteral
nutrition therapy given to patients. Bone disease, manifested by reduced bone
formation and demineralization in adults, and poor mineralization in infants, is
associated with bone aluminum
accumulation at the mineralizing surface. Aluminum
was first shown to contaminate casein hydrolysate, the parenteral nutrition
protein source. Substitution of amino acid solutions, low in aluminum,
reduced bone aluminum and improved
bone formation in adults. Alumium also accumulates ten-fold in the bones of
premature infants receiving chronic parenteral nutrition. Present sources of in
paranteral nutrition are calcium and phosphate salts, albumin, and heparin.
Although increased bone aluminum in
infants is not proven to cause disease, use of deferoxamine in one infant
produced hypocalcemia. This suggested that chelation of bone aluminum
by deferoxamine increased bone calcium uptake. Thus aluminum
in bone may impair bone calcium uptake and may contribute to the pathogenesis of
parenteral nutrition related bone disease in infants. Another complication of
parenteral nutrition therapy in infants is cholestatic liver disease, manifested
by reduced bile flow, and, occasionally, gallstones. Aluminum
has been found to accumulate in the livers of these infants, and there is
experimental evidence that aluminum
can reduce bile flow both in rats and in piglets. Aluminum
contamination of parenteral nutrition solutions puts infants at increased risk
for complications of parenteral nutrition therapy; amounts of aluminum
in parenteral nutrition solutions should therefore be minimized.
Skin, Eye and Respiratory Irritations:
May cause minor irritation to lungs &
eyes.
Drug Warnings:
The most frequent adverse effect of aluminum
antacids is constipation. Decreased bowel motility, dehydration, or fluid
restriction may predispose patients to intestinal obstruction. Hemorrhoids and
fissures, or fecal impaction may occur. In patients with chronic renal failure,
hyperaluminemia may occur and aluminum
may accumulate in bones, lungs, and nerve tissue. Aluminum
accumulation in the CNS may be the cause of dialysis dementia which sometimes
occurs in chronic renal failure patients receiving long-term aluminum
antacid therapy for hyperphosphatemia. Aluminum
intoxication with severe osteomalacia and extensive aluminum
deposition at the junction between calcified and noncalcified bone has been
reported in several young children who were receiving large dosages of aluminum
hydroxide for the management of hyperphosphatemia associated with azotemia; the
children were not undergoing hemodialysis during aluminum
hydroxide therapy. /Aluminum/
Aluminum
salts may cause phosphorus depletion which is generally negligible. However,
with prolonged administration or large doses, hypophosphatemia may occur,
especially in patients with inadequate dietary intake of phosphorus;
hypercalciuria secondary to bone resorption and increased intestinal absorption
of calcium results. This phosphorus depletion syndrome is characterized by
anorexia, malaise, and muscle weakness, and prolonged aluminum
antacid therapy may cause urinary calculi, osteomalacia, and osteoporosis. A
low-phosphorus diet, diarrhea, excessive phosphorus losses from malabsorption,
and restoration of renal function after a kidney transplant increase the
likelihood of the syndrome. Serum phosphate concentrations should be monitored
at monthly or bimonthly intervals in patients on maintenance hemodialysis who
are receiving chronic aluminum antacid
therapy. /Aluminum salts/
Aluminum
cmpd /in antacids/ cause constipation. /Aluminum
cmpd/
Medical Surveillance:
Employment and periodic physical examinations
should give special consideration to the skin, eyes and lungs. Lung function
should be followed.
Probable Routes of Human Exposure:
INTAKE OF ALUMINUM
IS CHIEFLY BY MOUTH, FROM FOODS AND BEVERAGES, ALSO BY LUNGS, FROM THE
ATMOSPHERIC DUST CONTENT. IT IS PRESENT IN NATURAL DIET, IN AMT VARYING FROM
VERY LOW IN ANIMAL PRODUCTS TO RELATIVELY HIGH IN PLANTS.
/INHALATION OF/ COARSER VARIETY OF ALUMINUM
DUST PRODUCED FROM MOLTEN METAL ... . /ALUMINUM
DUST/
WORKERS EXPOSED TO ... DUST OF ALUMINUM
METAL IN PRODUCTION OF EXPLOSIVES & FIREWORKS. /ALUMINUM
METAL/
In workers in bauxite mines, foundries, and
factories. In more than 1000 exposed workers given X-ray examinations of the
chest, pulmonary changes were found in 3.5 percent of those exposed to bauxite
dust, & in 4.9 percent exposed to cryolite dust in foundries and in factory
workers exposed to alumina. /Alumina/
Chronic fluorosis generally develops after
prolonged (10-20 years) exposure to industrial dusts, insecticides, or water
where fluorides exceed 3 to 4 ppm. This is especially true in workers involved
in the production of aluminum, steel,
or glass.
In children living in the vicinity of poorly
controlled aluminum smelters, variable
degrees of mottling of permanent teeth have been reported if exposure occurred
during the developmental phase of permanent teeth growth.
Electrolytic production of aluminum
can lead to a substantial exposure to fluorides and carcinogenic tar oils,
including polyaromatic hydrocarbons.
Primary aluminum
production plants are located in about 40 countries. The two main methods used
for aluminum production are Soderberg
and prebake, which encompass a number of processes and job categories.
Substantial exposures to airborne polynuclear aromatic compounds have been
measured in certain occupational settings in this industry. Exposures have been
higher in potrooms of plants using the Soderberg process than in those using the
prebake process; some workers may have exposed to both process. Exposures to
fluorides and a variety of other contaminants also occur in potrooms.
In aluminum
reduction plants ... from exposure to coal tar pitch volatiles and their
associated polycyclic aromatic hydrocarbons ... Among coke oven workers,
implicating coal tar pitch volatiles, a mutual exposure in aluminum
reduction plants ... .
Body Burden:
Aluminum
content of normal human brain ranged from 0.1-3.9 ug/g dry weight. In a study of
208 samples taken from 7 patients, ... a mean aluminum
content of 1.9 + or - 0.07 ug/g dry weight of gray matter /was found/ to be
abnormal. In a study of 585 areas sampled from the brain tissue of 10 patients
with Alzheimer's disease they found 28% had an aluminum
concn > 4 ug/g. The range of the 585 samples was 0.4-107 ug/g.
Average Daily Intake:
The daily ingestion of aluminum
by humans was estimated to be 30-50 mg.
Antidote and Emergency Treatment:
DIAGNOSIS: WHEN HISTORY IS UNATTAINABLE,
DIAGNOSIS DEPENDS ON THE DEMONSTRATION OF LARGE AMT OF ALUMINUM
IN VOMITUS, STOMACH CONTENTS OR FECES.
Deferoxamine has been used to treat dialysis
encephalopathy and osteomalacia with symptomatic relief reported. The use of
deferoxamine for aluminum-toxic
dialysis patients has been suggested for serum levels of aluminum
between 100 and 200 ug/ml. Deferoxamine also has been used to diagnose aluminum-related
osteodystrophy. After a deferoxamine infusion of 40 mg/kg over 2 hr, an
increment in plasma aluminum
concentration of 200 ug/l identified 35 of 37 patients with biopsy-proven aluminum-related
osteodystrophy (sensitivity, 94%; specificity, 50%). Calcium disodium
ethylenediaminetetraacetic acid does not appear as effective as deferoxamine in
chelating aluminum. Especially in
dialysis patients, aluminum-containing
medications should be reduced.
Animal Toxicity Studies:
Toxicity Summary:
IDENTIFICATION: Aluminum
is a silvery-white, ductile and malleable metal. It is released to the
environment both by natural processes and from anthropogenic sources. It is
highly concentrated in soil-derived dusts from such activities as mining and
agriculture, and in particulate matter from coal combustion. Aluminum
occurs ubiquitously in the environment in the form of silicates, oxides and
hydroxides, combined with other elements such as sodium and fluorine and as
complexes with organic matter. It is not found as a free metal because of its
reactivity. Aluminum metal has a wide
variety of uses, including structural materials in construction, automobiles and
aircraft, and the production of metal alloys. Aluminum
compounds and materials also have a wide variety of uses, including production
of glass, ceramics, rubber, wood preservatives, pharmaceuticals and
waterproofing textiles. Natural aluminum
minerals, especially bentonite and zeolite, are used in water purification,
sugar refining, brewing and paper industries. HUMAN EXPOSURE: Non-occupational
human exposure to aluminum in the
environment is primarily through ingestion of food and water. No acute
pathogenic effects in the general population have been described after exposure
to aluminum. Although it has been
hypothesized that aluminum is a risk
factor for Alzheimer's disease, present epidemiological evidence does not
support a causal association between Alzheimer's disease and aluminum
in drinking-water. Neurological syndromes including impairment of cognitive
function, motor dysfunction and peripheral neuropathy have been reported in
limited studies of workers exposed to aluminum
fume. Iatrogenic exposure in patients with chronic renal failure, exposed to aluminum-containing
dialysis fluids and pharmaceutical products, may cause encephalopathy,
vitamin-D-resistant osteomalacia and microcytic anemia. Premature infants may
develop increased tissue loading of aluminum,
particularly in bone, when exposed to iatrogenic sources of aluminum.
Although human exposure to aluminum is
widespread, in only a few cases has hypersensitivity been reported following
exposure to some aluminum compounds
after dermal application or parenteral administration. There is insufficient
information to allow for classification of the cancer risk from human exposures
to aluminum and its compounds. Aluminum
and its compounds appear to be poorly absorbed in humans. The mechanism of
gastrointestinal absorption of aluminum
has not yet been fully elucidated. The highest levels of aluminum
may be found in the lungs, where it may be present as inhaled insoluble
particles. The urine is the most important route of aluminum
excretion. ANIMAL STUDIES: The acute toxicity of metallic aluminum
and aluminum compounds is low. In
short-term studies using rats, mice or dogs to various aluminum
compounds in the diet or drinking-water, only minimal effects were observed at
the highest administered doses. Adequate inhalation studies were not identified.
Following intratracheal administration of aluminum
oxide, particle-associated fibrosis was observed. No overt fetotoxicity was
noted, nore were general reproductive parameters noted after gavage treatment of
rats. There is no indication that aluminum
is carcinogenic. It can form complexes with DNA and cross-link chromosomal
proteins and DNA, but it has not been shown to be mutagenic in bacteria or
induce mutation or transformation in mammalian cells in vitro. Chromosomal
aberrations have been observed in bone marrow cells of exposed mice and rats.
There is considerable evidence that aluminum
is neurotoxic in experimental animals, although there is considerable variation
among species. In susceptible species, toxicity following parenteral
administration is characterized by progressive neurological impairment,
resulting in death with status epilepticus. Osteomalacia, as it presents in man,
is observed consistently in larger species (e.g. dogs and pigs) exposed to aluminum;
a similar condition is observed in rodents. Absorption via the gastrointestinal
tract is usually less than one percent. Aluminum
is distributed in most organs within the body with accumulation occurring mainly
in bone at high dose levels. To a limited extent, aluminum
passes the blood-brain barrier and is also distributed to the fetus. Aluminum
is eliminated effectively by urine.
Non-Human Toxicity Excerpts:
... INHALATION OR INTRATRACHEAL INJECTION ...
OF ALUMINUM DUST CAUSED RESPIRATORY
INFECTIONS ... (RATS AND RABBITS) /SHOWED/ WIDESPREAD INTERSTITIAL FIBROSIS,
WITH HYALINOSIS, EMPHYSEMA AND HEMORRHAGES ... FROM WHICH OFTEN ARISE BULLOUS
EMPHYSEMA, BRONCHOPNEUMONIA & HEMORRHAGIC PNEUMONIA. THESE CHANGES WERE NOT
LIMITED TO THE PULMONARY PARENCHYMA BUT WERE PRESENT TO SOME DEGREE IN THE WALLS
OF THE BLOOD VESSELS AND IN THE KIDNEYS, AND SOME FIBROUS THICKENING OF
INTERSTITIAL TISSUE IN THE SPLEEN, LIVER AND MENINGES. /ALUMINUM
DUST/
IN ANIMALS ... INGESTION OF ALUMINUM
IN DIET IN /PROPORTION/ OF ... ABOUT 1400 PPM LOWERED LEVEL OF INORG PHOSPHORUS
IN BLOOD AND BONES ... CHICKENS DEVELOPED SEVERE RICKETS.
ALUMINUM
FILINGS & SPLINTERS EMBEDDED INTO THE SKIN DO NOT INDUCE A HYPERSENSITIVE
STATE.
... IT WAS CONCLUDED THAT "THERE WAS
EXPERIMENTAL EVIDENCE THAT IN ANIMALS INHALATION OF ALUMINUM
DUST AGGRAVATED PULMONARY TUBERCULOSIS."
VERY FINE ALUMINUM
POWDERS ... WERE NOT FIBROGENIC IN RATS, GUINEA PIGS, & HAMSTERS WHEN
INHALED; ALVEOLAR PROTEINOSIS WAS CONSISTENT FINDING, CONDITION NOT REPORTED IN
FATAL CLINICAL CASES OF ALUMINOSIS. FOCAL PULMONARY FIBROSIS SEEN IN RATS ARISES
FROM ARTIFACTUAL INTRATRACHEAL INJECTION OF ... 100 MG/RAT.
SC IMPLANTED ... ALUMINUM
FOIL INDUCED SARCOMAS IN 8 OUT OF 18 RATS; PARTICULATE SMOOTH SURFACE APPEARED
TO CONTRIBUTE TO THE CARCINOGENIC ACTIVITY. FOLLOWING INHALATION, DUST OF ALUMINUM
... IN RATS, INITIAL REPONSE TO ... DEPOSIT WAS PROLIFERATION OF MACROPHAGES
WITHIN ALVEOLAR SPACES, RESULTING IN LIPOID PNEUMONIA; PROLONGED EXPOSURE CAUSED
FOCAL DEPOSITS OF HYALINE MATERIAL IN ALVEOLAR WALLS.
In a 16 wk greenhouse study, forest soil
samples representing three soil series were used as growth media: Captina (Fragiudult,
MO), Lexington (Paleudalf, MS) and Becket (Fragiorthod, NY). Soil from two
horizons from each series was separately amended in 4 treatments for a wide
range of soil aluminum availability:
control, limed calcium hydroxide, acidified (hydrogen chloride), acidified with
supplemental calcium added (+ hydrogen chloride and calcium sulfate. .
Treatments significantly (p< 0.05) altered soil pH (range 3.65 to 5.48), base
saturation, and 0.01 M strontium chloride-extractable aluminum
(range 0.6-37.2 mg/kg). Fifteen dormant, 1 yr old, bare-root northern red oak (Quercus
rubra) seedlings were distributed to each soil horizon-treatment cell (6
horizons by 4 treatments by 15 seedlings = 360 seedlings); one seedling from
each of 15 size classes was assigned to each cell. Compared to controls, both
acidification treatments resulted in significant reductions in fine root and
foliar biomass production and in fine root branching in all horizons, except the
highly organic Bhs of the Fragiorthod. In the remaining five horizons, fine root
branching and biomass production were highly and negatively correlated (R
squared= 0.70 and 0.50, respectively) with 0.01 M strontium chloride-extractable
aluminum. Although fine root tissue
concn of aluminum correlated highly
with 0.01 M strontium chloride -extractable aluminum
levels, root tissue aluminum predicted
root branching and biomass only moderately well (R squared= 0.30 and 0.21,
respectively). Fine root branching was more sensitive to treatment effects than
either root biomass production or root elongation.
The effect of aluminum
(3+) on superoxide dismutase in vitro was studied, since in uremia there is
excessive superoxide production and frequently an elevated serum A1(3+) level.
Thus, the protective role of superoxide dismutase is particularly important.
Al(+3) in concentrations similar to those found in the serum of uremic patients
inhibits superoxide dismutase activity. The degree of inhibition is directly
proportionl to the Al(3+) level. The combination of excessive oxygen free
radical production with an increased Al(3+) level may contribute to a variety of
complications, including aluminum
dementia or initiation and promotion of carcinogenic process, which are known to
be more common in uremic patients.
Animal studies show that aluminum
particles, in particular stamped aluminum
powder, may cause fibrosis of the lung whereas particles of aluminum
compounds appear to be less reactive. /Aluminum
powder/
Severe aluminum
intoxication following parenteral or oral administration of aluminum
hydroxide, chloride, or sulfate to rats is characterized by lethargy, anorexia,
or death. Other /studies/ ... have found that intratracheal instillation of aluminum
salts or metallic aluminum powder has
produced pulmonary fibroses. Injected intraperitoneally, aluminum
compounds produce fibrotic peritonitis. /Aluminum
cmpd/
Aluminum
salts are much more toxic intravenously than by mouth to animals. The mechanism
of this presumable systemic effect of aluminum
is not known. /Aluminum salts/
Because aluminum
is only sparingly absorbed from the gut, LD50 values for aluminum
ingestion are unavailable, since death occurs from intestinal blockage due to
precipitated aluminum species rather
than systemic aluminum toxicity.
Chronic, oral administration of aluminum
to rats increases the in vivo concentration of cyclic AMP and the
phosphorylation of microtubule-associated protein-2 (MAP-2) and the 200 kd
neurofilament subunit. In the present study, the effect of this treatment on
endogenous protein phosphorylation in soluble and particulate fractions prepared
from cerebral cortices was examined. Chronic aluminum
treatment significantly elevated the basal and cyclic AMP-dependent
phosphorylation of 11-12 endogenous proteins in the soluble fraction prepared
from cerebral cortices. Endogenous protein phosphorylation in the soluble
fraction occurring in the presence of calcium (+2) alone or calcium (+2) phorbol
12-myristate 13-acetate and phosphatidylserine was not significantly altered by aluminum
treatment. In the particulate fraction the phosphorylatin of several proteins
was significantly decreased by aluminum
administration; however the phosphorylation of the majority of protein sustrates
remained unaltered. Aluminum treatment
did not alter the activities of cyclic AMP-dependent protein kinase or protein
tyrosine kinase in the soluble and particulate fractions. The activity of
calcium (+2) /phospholipid-dependent protein kinase (proteinkinase C) was
increased in the particulate fraction of aluminum-fed
rats. These results clearly demonstrate that specific effects on protein kinase
activities results fromin vivo aluminum
administration.
Aluminum
compounds have been evaluated as non-mutagenic by most standard methods of
mutagenic assays. /Aluminum cmpd/
Absorption, Distribution & Excretion:
It was calculated that a dialysate aluminum
concn of 0.2-1.0 mg/l (a concn readily found in many water supplies) would
result in the direct transfer of aluminum
into the blood of 3-16 mg for each dialysis treatment or 42-211 mg/mo.
A given oral dose of aluminum
results in significantly higher serum and tissue levels of the metal in
nephrectomized rats than in intact controls in spite of the fact that only
minimal amounts of aluminum are
normally excreted in the urine.
It was found that 70-90% of total aluminum
bound to plasma proteins (60-70% to a high molecular weight protein and 10-20%
to albumin while only 10-30% was unbound). This high affinity of aluminum
for plasma proteins strongly suggests high levels of binding of aluminum
to a variety of tissue proteins.
It was shown that the uptake of aluminum
into the blood during renal dialysis was due to the extensive binding of aluminum
to plasma proteins leaving very little aluminum
in the non-bound state in plasma. Thus, the plasma proteins served as a trap for
accumulating the metal. It was shown that the component of plasma protein that
binds aluminum is saturable.
Consistent with this ... is the fact that, during dialysis with aluminum-containing
dialysate, plasma aluminum levels
reach a plateau.
Renal clearance of aluminum
has been shown to be approximately 5-10% of that of urea or creatinine
clearance. This is entirely consistent with the marked protein binding of aluminum
in plasma, thus leaving only a small fraction of the total aluminum
available for filtration in the kidney.
That the kidney is responsible for the
elimination of a major portion of absorbed aluminum
is reflected in the fact that, in dogs undergoing renal dialysis ligation of the
ureter (resulting in cessation of urinary output) causes a greater increase in
plasma aluminum concn than in intact
dogs undergoing comparable dialysis.
The 200-300 mg of aluminum/kg
tissue weight is most likely due to local deposition of particulate aluminum
from the air following inhalation and not due to a specific predilection of lung
tissue for aluminum. Aluminum
has been reported in both non-urban and urban air with the latter containing as
much as 10 ug/cu m.
The aluminum
content of gray matter of brain (essentially the inner cellular mass of the
brain) was not significantly different than that in the white matter (the outer
myelinated fibers of the brain).
SINCE LITTLE ALUMINUM
IS ABSORBED, IT IS EXCRETED IN THE FECES, MUCH OF IT IN THE FORM OF ALUMINUM
PHOSPHATE. THERE IS NO INCR IN THE AMT OF ALUMINUM
IN TISSUES, EXCEPT IN BONE (ANIMAL EXPERIMENTS).
AMT OF ALUMINUM
IN TISSUES, ORGANS, BLOOD & URINE IS SMALL. ADULT HUMAN BODY MAY CONTAIN
50-150 MG ... AFTER INGESTION OF LARGE AMT VERY LITTLE APPEARS IN URINE ...
BETWEEN 50 & 100 MG DAILY FOR ABOUT 70 DAYS.
Cations that form insoluble phosphates
interfere with the absorption of phosphorus. For example, high intakes of aluminum
decrease absorption of phosphorus (as phosphate) by forming insoluble aluminum
phosphate and increasing the excretory loss of phosphorus.
Absorption of inhaled aluminum
compounds has not been studied in detail; one reason for this is probably the
fact that no stable radioactive isotope of aluminum
is available. Workers exposed to aluminum
in connection with the production of raw aluminum,
aluminum sulfate, corundum or welding
of aluminum have elevated levels of aluminum
in urine. This is evidence of pulmonary absorption. ... Measured the total
urinary elimination of aluminum in
three volunteers exposed to respirable aluminum
fume from welding. The urinary excretion was 0.1-0.3% of the estimated inhaled
amount. In experimental animals exposed to aluminum
oxide as well as in humans occupationally exposed to aluminum
particles, inhaled or deposited particles of aluminum
may be retained in the lungs over long periods of time. /Aluminum
cmpd/
Studies ... strongly suggest that aluminum
in the gastrointestinal tract and its subsequent distribution in tissue can be
influenced by increasing the concentration of parathyroid hormone. They fed male
rats aluminum as 0.1% of their diet
for 25 days. The ready absorption of aluminum
from the gastrointestinal tract of these normal rats was enhanced by injections
of parathyroid hormone (17 U twice weekly). There was also increased deposition
of the metal in the kidney, muscle, bone, and the gray matter of the brain, but
not in the liver or in the white matter of the brain. Thus, the parathyroid
hormone exerted a specific effect on the absorption and distribution of aluminum.
In 1977, ... a positive correlation between increased serum parathyroid hormone
and serum aluminum levels in dialysis
patients ... had been reported.
Trace determination of aluminum
was carried out in blood samples from 11 patients with chronic renal failure
undergoing periodical hemodialysis treatment. Analysis for aluminum
was made by graphite furnace atomic absorption spectrometry in samples taken at
the beginning and end of dialysis, and of dialysate from the inflow (pre) and
outflow (post) lines of dialyzers. Healthy individuals, without history of renal
disease, were used as controls. The aluminum
concn in pre- and post-dialysis whole blood was 58 + or - 9 ug/l and 139 + or -
19 ug/l, respectively. The aluminum
concn in pre- and post-dialysate was 235 + or - 39 ug/l and 129 + or - 10 ug/l,
respectively. Blood aluminum concn of
control subjects did not show significant differences when compared with data
reported by other authors. Aluminum
was transferred to the patients' blood during the dialysis treatments, because
of the high metal content in the tap water used to prepare the dialysates. /Aluminum/
ALUMINUM
IN LUNGS IS PROBABLY RESULT OF LOCAL DEPOSITION FROM INHALED AIR.
ALUMINUM
SALTS ARE ABSORBED IN ... SMALL AMT FROM THE DIGESTIVE TRACT. /ALUMINUM
SALTS/
In dogs undergoing renal dialysis ligation of
the ureter (resulting in cessation of urinary output), there is a greater
increase in plasma aluminum concn than
in intact dogs undergoing comparable dialysis. This indicates that the kidney is
responsible for the elimination of a major portion of absorbed aluminum.
/Aluminum/
Biological Half-Life:
The mean plasma half-life of aluminum
after iv admin in dogs is approx 4.5 hr.
The shorter half-life for the urinary
elimination of aluminum was about 8
hr.
Mechanism of Action:
Excessive dietary aluminum
has been proposed to be a factor contributing to several neurological disorders
in humans. Six 8-week-old female Swiss Webster mice were fed for 10 wk purified
diets containing 100 (control), 500 or 1000 ug aluminum/g
diet. Brain and liver lipid peroxidation was determined by evaluating the
production of 2-thiobarbituric acid reactive substances in brain and liver
homogenates in the presence or absence of 50 uM ferrous iron. 2-Thiobarbituric
acid reactive substances production in the absence of iron in brain homogenates
from mice fed the 1000 ug/g diet was higher (30%) than that in the 100 ug/g
control group (3.1 vs 2.4 nmol 2-thiobarbituric acid reactive substances/mg
protein). The addition of ferrous iron increased 2-thiobarbituric acid reactive
substances production in brain homogenates from all 3 dietary groups. The iron
induced 2-thiobarbituric acid reactive substances production was 26% higher in
the 1000 ug/g brain homogenates than in the 100 ug/g group (4.9 vs 3.9 nmol
2-thiobarbituric acid reactive subtances/mg protein). Brain 2-thiobarbituric
acid reactive substances production in the presence and absence of iron was
similar between the 100 and 500 ug/g aluminum
groups. 2-Thiobarbituric acid reactive substances production in liver
homogenates measured either with or without iron was similar for the 3 groups.
These results show that, in mice, dietary aluminum
intoxication leads to increased brain 2-thiobarbituric acid reactive substance
production, suggesting that enhanced lipid peroxidation may be one possible
mechnism underlying the neurological damage associated with increased tissue aluminum.
Interactions:
Groups of 120 Atlantic salmon fry (Salmo salar,
1 g mass) were kept in through-flow tanks of water (pH 5) containing various
concn of aluminum and silicic acid.
The aluminum concn in all but the
control tank (0.85 umol aluminum/l)
were 6-7 umol/l, at acutely toxic levels. Silicon levels were 0.66 umol/l
(control), 93.06, 24.89, 5.46, and 0.60 umol/l, corresponding to silicon:aluminum
ratios of 13.0, 3.7, 0.9, and 0.1. Exchangeable aluminum,
ie, aluminum retained on Amberlite,
was 6.00, 5.00, 4.11, and 1.52 umol/l in test tanks, respectively. Fish were
exposed for 96 hr, and the proportion of dead fish was recorded at 12-hr
intervals. The whole experiment was run three times; data are from all runs
combined. At a silicon:aluminum ratio
of 13, acute toxicity of aluminum was
eliminated and gill structures of the fish were normal. Percent survival versus
time was higher for the higher silicon:aluminum
ratio groups. Accumulation of aluminum
by fish fell sharply as the exchangeable aluminum
increased. Aluminum and silicon levels
in fish were 0.44 and 0.01 (control), 0.40 and 0.54 (silicon:aluminum
ratio of 13), 2.04 and 0.35 (silicon:aluminum
ratio of 3.7), 2.49 and 0.33 (silicon :aluminum
ratio of 0.9), 2.38 and 0.08 (silicon:aluminum
ratio of 0.1) umol per g dry mass, respectively.
To elucidate the interaction between aluminum
and certain essential trace metals, an experiment was performed on rats fed
diets with suboptimal or optimal levels of zinc or copper. Half of each group of
animals were fed the same diet but with 1000 ppm aluminum
added. Changes were noted after 120 days. Severe testicular damage was seen in
rats fed either the low zinc or the low copper diet. The lesions included a wide
range of spermatogenic cell degeneration and tubular atropy. When aluminum
was added to the diet, the testicular destruction of zinc deficient rats was
significantly reduced. This indicated that the presence of aluminum
in the diet protected the testis against the damage caused by zinc deficiency.
Pituitary glands were examined. Hypertrophy of basophils was more pronounced in
rats fed the suboptimal zinc or copper diet. When aluminum
was added to their diet, the changes were reversed. The mechanisms by which aluminum
protects male gonadal functions against zinc deficiency are discussed. This
study is the first to demonstrate the preventive effect of aluminum
against testicular damage caused by zinc deficiency.
Adult, male New Zealand rabbits (three per
group) were administered drinking water containing aluminum
chloride (0, 100, or 500 mg aluminum/liter)
together with citrate (0.11 M) ascorbate (0.11 M), or no added ligand and
libitum for 12 weeks. They were fed ad libitum regular rabbit chow analyzed to
contain 297 mg aluminum/kg. Treatment
had no effect upon food and water intake or weight gain during the experimental
period. No effect of aluminum was
observed on tissue levels of the essential metals zinc, copper, and iron, or on
hemoglobin and hematocrit values. Aluminum
levels were fund to increase in a dose-dependent manner in stomach and
intestinal mucosa, kidney, bone, urine, and fece. There was only a slight
accumulation in liver, and no accumulation in brain (cerebral cortex or
hippocampus). Although plasma aluminum
was directly related to aluminum
intake, whole blood aluminum bore no
relation to aluminum dose. Citrate had
no efefct on aluminum accumulation in
the stomach or intestine, but significantly enhanced plasma and bone aluminum
levels. Ascorbate did not enhance aluminum
accumulation in any tissue studied and even prevented accumulation in bone. Both
citrate and ascorbate enhanced excretion of aluminum.
Ascorbate therapy may be of potential clinical use to enhance aluminum
excretion.
Therapeutic Uses:
Medicinally, aluminum
and its salts are used in antacids, antidiarrheals, and protective
dermatological pastes. It is also found in cosmetics and deodorants. /Aluminum
and its salts/
Aluminum
foil has been used as a dressing for burns. /Aluminum/
Aluminum
powder has been used for dusting the skin around an ileostomy, caecostomy, or
colostomy to prevent irritation due to proteolytic or irritant discharges. The
skin is dried and freed from grease and repeated applications of the powder made
until a thick film adheres. Alternatively, Compound Aluminum
Paste may be employed; the paste is applied thickly round the fistula or sinus
in order to prevent the discharge from coming in contact with the skin. Aluminum
powder has been used as a dressing for burns, /topical/ ulcers, and indolent
wounds. /Aluminum powder/
Drug Warnings:
The most frequent adverse effect of aluminum
antacids is constipation. Decreased bowel motility, dehydration, or fluid
restriction may predispose patients to intestinal obstruction. Hemorrhoids and
fissures, or fecal impaction may occur. In patients with chronic renal failure,
hyperaluminemia may occur and aluminum
may accumulate in bones, lungs, and nerve tissue. Aluminum
accumulation in the CNS may be the cause of dialysis dementia which sometimes
occurs in chronic renal failure patients receiving long-term aluminum
antacid therapy for hyperphosphatemia. Aluminum
intoxication with severe osteomalacia and extensive aluminum
deposition at the junction between calcified and noncalcified bone has been
reported in several young children who were receiving large dosages of aluminum
hydroxide for the management of hyperphosphatemia associated with azotemia; the
children were not undergoing hemodialysis during aluminum
hydroxide therapy. /Aluminum/
Aluminum
salts may cause phosphorus depletion which is generally negligible. However,
with prolonged administration or large doses, hypophosphatemia may occur,
especially in patients with inadequate dietary intake of phosphorus;
hypercalciuria secondary to bone resorption and increased intestinal absorption
of calcium results. This phosphorus depletion syndrome is characterized by
anorexia, malaise, and muscle weakness, and prolonged aluminum
antacid therapy may cause urinary calculi, osteomalacia, and osteoporosis. A
low-phosphorus diet, diarrhea, excessive phosphorus losses from malabsorption,
and restoration of renal function after a kidney transplant increase the
likelihood of the syndrome. Serum phosphate concentrations should be monitored
at monthly or bimonthly intervals in patients on maintenance hemodialysis who
are receiving chronic aluminum antacid
therapy. /Aluminum salts/
Aluminum
cmpd /in antacids/ cause constipation. /Aluminum
cmpd/
Interactions:
Groups of 120 Atlantic salmon fry (Salmo salar,
1 g mass) were kept in through-flow tanks of water (pH 5) containing various
concn of aluminum and silicic acid.
The aluminum concn in all but the
control tank (0.85 umol aluminum/l)
were 6-7 umol/l, at acutely toxic levels. Silicon levels were 0.66 umol/l
(control), 93.06, 24.89, 5.46, and 0.60 umol/l, corresponding to silicon:aluminum
ratios of 13.0, 3.7, 0.9, and 0.1. Exchangeable aluminum,
ie, aluminum retained on Amberlite,
was 6.00, 5.00, 4.11, and 1.52 umol/l in test tanks, respectively. Fish were
exposed for 96 hr, and the proportion of dead fish was recorded at 12-hr
intervals. The whole experiment was run three times; data are from all runs
combined. At a silicon:aluminum ratio
of 13, acute toxicity of aluminum was
eliminated and gill structures of the fish were normal. Percent survival versus
time was higher for the higher silicon:aluminum
ratio groups. Accumulation of aluminum
by fish fell sharply as the exchangeable aluminum
increased. Aluminum and silicon levels
in fish were 0.44 and 0.01 (control), 0.40 and 0.54 (silicon:aluminum
ratio of 13), 2.04 and 0.35 (silicon:aluminum
ratio of 3.7), 2.49 and 0.33 (silicon :aluminum
ratio of 0.9), 2.38 and 0.08 (silicon:aluminum
ratio of 0.1) umol per g dry mass, respectively.
To elucidate the interaction between aluminum
and certain essential trace metals, an experiment was performed on rats fed
diets with suboptimal or optimal levels of zinc or copper. Half of each group of
animals were fed the same diet but with 1000 ppm aluminum
added. Changes were noted after 120 days. Severe testicular damage was seen in
rats fed either the low zinc or the low copper diet. The lesions included a wide
range of spermatogenic cell degeneration and tubular atropy. When aluminum
was added to the diet, the testicular destruction of zinc deficient rats was
significantly reduced. This indicated that the presence of aluminum
in the diet protected the testis against the damage caused by zinc deficiency.
Pituitary glands were examined. Hypertrophy of basophils was more pronounced in
rats fed the suboptimal zinc or copper diet. When aluminum
was added to their diet, the changes were reversed. The mechanisms by which aluminum
protects male gonadal functions against zinc deficiency are discussed. This
study is the first to demonstrate the preventive effect of aluminum
against testicular damage caused by zinc deficiency.
Adult, male New Zealand rabbits (three per
group) were administered drinking water containing aluminum
chloride (0, 100, or 500 mg aluminum/liter)
together with citrate (0.11 M) ascorbate (0.11 M), or no added ligand and
libitum for 12 weeks. They were fed ad libitum regular rabbit chow analyzed to
contain 297 mg aluminum/kg. Treatment
had no effect upon food and water intake or weight gain during the experimental
period. No effect of aluminum was
observed on tissue levels of the essential metals zinc, copper, and iron, or on
hemoglobin and hematocrit values. Aluminum
levels were fund to increase in a dose-dependent manner in stomach and
intestinal mucosa, kidney, bone, urine, and fece. There was only a slight
accumulation in liver, and no accumulation in brain (cerebral cortex or
hippocampus). Although plasma aluminum
was directly related to aluminum
intake, whole blood aluminum bore no
relation to aluminum dose. Citrate had
no efefct on aluminum accumulation in
the stomach or intestine, but significantly enhanced plasma and bone aluminum
levels. Ascorbate did not enhance aluminum
accumulation in any tissue studied and even prevented accumulation in bone. Both
citrate and ascorbate enhanced excretion of aluminum.
Ascorbate therapy may be of potential clinical use to enhance aluminum
excretion.
Drug Idiosyncrasies:
Contact allergy to aluminum
has been reported in a few cases. This type of allergy must be regarded very
rare, considering the common exposure to the metal itself & the use of aluminum
chloride hexahydrate in deodorants. /Aluminum
chloride hexahydrate/
Environmental Fate & Exposure:
Probable Routes of Human Exposure:
INTAKE OF ALUMINUM
IS CHIEFLY BY MOUTH, FROM FOODS AND BEVERAGES, ALSO BY LUNGS, FROM THE
ATMOSPHERIC DUST CONTENT. IT IS PRESENT IN NATURAL DIET, IN AMT VARYING FROM
VERY LOW IN ANIMAL PRODUCTS TO RELATIVELY HIGH IN PLANTS.
/INHALATION OF/ COARSER VARIETY OF ALUMINUM
DUST PRODUCED FROM MOLTEN METAL ... . /ALUMINUM
DUST/
WORKERS EXPOSED TO ... DUST OF ALUMINUM
METAL IN PRODUCTION OF EXPLOSIVES & FIREWORKS. /ALUMINUM
METAL/
In workers in bauxite mines, foundries, and
factories. In more than 1000 exposed workers given X-ray examinations of the
chest, pulmonary changes were found in 3.5 percent of those exposed to bauxite
dust, & in 4.9 percent exposed to cryolite dust in foundries and in factory
workers exposed to alumina. /Alumina/
Chronic fluorosis generally develops after
prolonged (10-20 years) exposure to industrial dusts, insecticides, or water
where fluorides exceed 3 to 4 ppm. This is especially true in workers involved
in the production of aluminum, steel,
or glass.
In children living in the vicinity of poorly
controlled aluminum smelters, variable
degrees of mottling of permanent teeth have been reported if exposure occurred
during the developmental phase of permanent teeth growth.
Electrolytic production of aluminum
can lead to a substantial exposure to fluorides and carcinogenic tar oils,
including polyaromatic hydrocarbons.
Primary aluminum
production plants are located in about 40 countries. The two main methods used
for aluminum production are Soderberg
and prebake, which encompass a number of processes and job categories.
Substantial exposures to airborne polynuclear aromatic compounds have been
measured in certain occupational settings in this industry. Exposures have been
higher in potrooms of plants using the Soderberg process than in those using the
prebake process; some workers may have exposed to both process. Exposures to
fluorides and a variety of other contaminants also occur in potrooms.
In aluminum
reduction plants ... from exposure to coal tar pitch volatiles and their
associated polycyclic aromatic hydrocarbons ... Among coke oven workers,
implicating coal tar pitch volatiles, a mutual exposure in aluminum
reduction plants ... .
Body Burden:
Aluminum
content of normal human brain ranged from 0.1-3.9 ug/g dry weight. In a study of
208 samples taken from 7 patients, ... a mean aluminum
content of 1.9 + or - 0.07 ug/g dry weight of gray matter /was found/ to be
abnormal. In a study of 585 areas sampled from the brain tissue of 10 patients
with Alzheimer's disease they found 28% had an aluminum
concn > 4 ug/g. The range of the 585 samples was 0.4-107 ug/g.
Average Daily Intake:
The daily ingestion of aluminum
by humans was estimated to be 30-50 mg.
Natural Pollution Sources:
WIDELY DISTRIBUTED IN EARTH'S CRUST IN
COMBINATION WITH OXYGEN, FLUORINE, SILICON AND OTHER CONSTITUENTS. ITS MOST
IMPORTANT SOURCES FROM THE INDUSTRIAL POINT OF VIEW ARE BAUXITE, CRYOLITE, ALUMINUM
, CORUNDUM AND THE KAOLIN MINERALS.
DOES NOT OCCUR FREE IN NATURE.
2 ug/l of aluminum
occurs in a dissolved state in seawater. The species in solution is Al(OH)4-1.
Artificial Pollution Sources:
Deposited on boiler tubes due to corrosion
effects /in processing of coal/.
Environmental Fate:
TERRESTRIAL FATE: Air-dried, <2 mm
fractions of 3 soil samples from The Netherlands and 1 from New Hampshire, were
taken from the surface and sub-surface horizons of two podzols (Haplorthods) and
of a recent driftsand (Udipsamment). Duplicate samples of each emulsion soil
horizon were leached ... with aqueous hydrogen chloride (pH 3.0). ... Charge
balances of the leachates indicate that dissolved aluminum
is present mainly as aquo-aluminum(+3).
Only in leachates of podzol Bhs horizons is a significant fraction (20-30%) of
dissolved aluminum organically
complexed. Dissolved aluminum concn
are significantly correlated with the organic (Na4P2O7-extractable) aluminum
content of the soil sample. Mobility of aluminum
in the Hubbard Brook soils is significantly lower than in the Dutch soils,
because of higher soil-solution pH values. /Aluminum
cmpd/
Albic and spodic soil horizons were sampled
from old growth eastern white pine/mixed northern hardwoods. Adirondacks, and an
ochric soil horizon was sampled from the Appalachian plateau of NY State. 21
Three-horizon forest floor and 21 forest floor/mineral soil (field moist
equivalent of 12.0 oven-dry albic, spodic, or ochric mineral soil) columns were
leached in triplicate with either 10 uM nitric acid (pH 5), 5 uM sulfuric acid
(pH 5), 100 uM nitric acid (pH 4), 50 uM sulfuric acid (pH 4), 1000 uM nitric
acid (pH 3), 500 uM sulfuric acid (pH 3), or distilled, deionized water ((pH
5.7) control treatment). Nitric acid leached more aluminum
than did sulfuric acid from forest floor/spodic soil columns. Increasing the
nitric acid concn from pH 3-5 increased total aluminum
concn in leachates from 0.70 to 0.85 mM, while increasing sulfuric acid had no
effect. Addition of pH 3 sulfuric acid to forest floor/spodic columns raised
leachate pH relative to pH 3 nitric acid and controls, and resulted in the
lowest aluminum concn of all
treatments in the first 3 of 4 sequential leachings. /Aluminum/
Albic and spodic soil horizons were sampled
from old growth eastern white pine/mixed northern hardwoods sites in the
Adirondacks, and an ochric soil horizon was sampled from the Appalachian Plateau
of NY State. 9 Three-horizon forest floor (FF), 9 mineral soil (field moist
equivalent of 12.0 oven-dry albic, spodic, or ochric mineral soil) and 9 forest
floor/mineral soil columns were leached with 60 ml of (a) 10 mM ammonium nitrate
(control), (b) 1.0 mM nitric acid in 10 mM ammonium nitrate (pH 3), and (c) 1.0
mM ammonium nitrate (pH 3) at the rate of 10 ml/h. The above procedure was
repeated on each mineral soil without a forest floor, except leaching soln were
0.5 mM calcium nitrate or calcium sulfate, each in 10 mM ammonium nitrate.
Adding 2 and 0.5 cmol sub c (H+)/kg to forest floor and mineral soils,
respectively, simulated snowmelt additions. Total aluminum
concn in leachates from forest floor/albic or forest floor/ochric columns were
greater than the sum of concn in leachates from the forest floor and mineral
horizon when leached separately. This positive synergistic behavior of the
forest floor-mineral horizon sequences was also observed in the forest floor-spodic
horizon sequence when leached with control soln, but the synergism was negative
for both labile and non-labile aluminum
when leached with the acids. Sulfuric acid leached less aluminum
from the spodic horizon than did nitric acid, regardless of the presence of a
forest floor, but nitric acid, sulfuric acid , and control soln leached similar
concn of aluminum from the albic and
ochric horizons. The forest floor effects on the mineral soil leachates were
attributed to effects of calcium, sulfate, nitrate, and dissolved organic C
leached from the forest floor to the mineral horizon since forest floor removed
nearly all added H+. /Aluminum/
Environmental Water Concentrations:
The solute and particulate aluminum
chemistry of a relatively unpolluted snowfall associated with a maritime airmass
was measured by neutron activation analysis and inductively-coupled plasma
analysis (soluble fraction) and neutron activation analysis (particulate
material), to characterize background conditions for the Scottish Highlands. Aluminum
concentrations were compared to those found in a polluted black snowfall with a
trajectory that originated over eastern Europe and to those levels found in
seasonal snowpack. The variability of the concentration of solute and the
chemical composition of particulate material is reported on an intra-and
inter-site basis. The solute aluminum
content of Scottish snowfall in the inter-site survey was 19.2 ug/l, and in the
intra-site survey 52.2 ug/l. The aluminum
composition of particulate matter found within Scottish snow was 20,600 ppm in
the inter-site survey, and 21,100 ppm in the intra-site survey. For the black
snow, the solute aluminum content was
84 + or - 3 ug/l, and the aluminum
composition of particulate matter was 52,300 ppm. The mean concentration of aluminum
in seasonal snowpack was 27,200 ppm. /Aluminum
solute & particulate/
Sediment/Soil Concentrations:
CONCN ... AS HIGH AS 150-600 G/KG HAVE BEEN
REPORTED IN SOIL.
Concn in soils vary ... solubility ...
determined by pH.
Comparison was made between the chemical
composition of soil solutions from spruce plantation soil in Denmark isolated by
means of a suction method using porcelain cups and by centrifugation. The soil
solutions were isolated from 3 depths of field plots, where the soil (Typic
Haplohumod) had been subjected to various pretreatments. The cups were made of
mullite (aluminum oxide. silicon
oxide/aluminum oxide Silicon oxide and
corundum (aluminum oxide) as shown by
X-ray diffraction analysis.
Atmospheric Concentrations:
CONTENT IN URBAN AIR IS REPORTED UP TO ABOUT
10 UG/CU M; IN NONURBAN AREAS VALUES LOWER THAN 0.5 UG/CU M ... .
Food Survey Values:
IT IS PRESENT IN NATURAL DIET, IN AMT VARYING
FROM VERY LOW IN ANIMAL PRODUCTS TO RELATIVELY HIGH IN PLANTS.
Environmental Standards & Regulations:
Federal Drinking Water Guidelines:
EPA 50-200 ug/l
State Drinking Water Standards:
(CA) CALIFORNIA 1000 ug/l
State Drinking Water Guidelines:
(AZ) ARIZONA 73 ug/l
(CA) CALIFORNIA 200 ug/l
(ME) MAINE 1430 ug/l
FDA Requirements:
Aluminum
is an indirect food additive for use only as a component of adhesives.
Aluminum
powder shall conform to the following specifications: fineness, 100% shall pass
through a 200-mesh screen and 95% shall pass through a 325-mesh screen; mercury,
not more than 1 ppm; arsenic, not more than 3 ppm; lead, not more than 20 ppm;
and aluminum, not less than 99% ... Aluminum
powder is safe for use in externally applied drugs ... in amt consistent with
good manufacturing practice. ... Certification of this color additive is not
necessary for the protection of the public health and therefore batches thereof
are exempt from the certification pursuant to section 706(c) of the /Federal
Food, Drug, and Cosmetic Act (as ammended)/. /Aluminum
powder/
Aluminum
powder may be safely used in coloring externally applied cosmetics ... in amt
consistent with good manufacturing practice. ... Certification of this color
additive is not necessary for the protection of the public health, and therefore
batches thereof are exempt from the certification pursuant to section 706(c) of
the /Federal Food, Drug and Cosmetic Act (as amended/. /Aluminum
powder/
Chemical/Physical Properties:
Molecular Formula:
Al
Molecular Weight:
26.98
Color/Form:
TIN-WHITE, MALLEABLE, DUCTILE METAL, WITH
SOMEWHAT BLUISH TINT
SILVER WHITE DUCTILE METAL, CUBIC
CRYSTALLINE SOLID
Silvery-white, malleable, ductile ... metal.
Odor:
... Odorless ...
Boiling Point:
2327 DEG C
Melting Point:
660 DEG C
Density/Specific Gravity:
2.70
Solubilities:
SOL IN ALKALIES, HYDROCHLORIC ACID, SULFURIC
ACID; INSOL IN CONCN NITRIC ACID, HOT ACETIC ACID; INSOL IN COLD & HOT WATER
Vapor Pressure:
1 MM HG @ 1284 DEG C
Other Chemical/Physical Properties:
DOES NOT VAPORIZE EVEN @ HIGH TEMP; CAPABLE OF
TAKING BRILLIANT POLISH WHICH IS RETAINED IN DRY AIR; REDUCES THE CATIONS OF
MANY HEAVY METALS TO THE METALLIC STATE ... IN MOIST AIR, OXIDE FILM FORMS WHICH
PROTECTS METAL FROM CORROSION; ... NATURALLY OCCURRING ISOTOPE: (27)ALUMINUM;
IN ADDN, 6 RADIOACTIVE ISOTOPES & 1 ISOMER ARE KNOWN
GOOD CONDUCTOR OF HEAT & ELECTRICITY
TENSILE STRENGTH (ANNEALED) 6800 PSI, COLD
ROLLED 16,000 PSI; RAPIDLY OXIDIZED BY WATER @ 180 DEG C